For the Quarter Ending March 2024
North America
In Q1 2024, the pricing of Terbinafine Hydrochloride in the North America region experienced notable fluctuations, reflecting the complex interplay of various factors shaping market conditions. The pricing trend throughout the quarter exhibited a mixed pattern, characterized by shifts in both supply and demand dynamics, alongside external factors influencing the market.
The price trajectory of Terbinafine Hydrochloride in the region showed increases in January, followed by declines in February and March. At the onset of the quarter, prices surged due to heightened buying activity in downstream sectors such as pharmaceuticals and healthcare. Additionally, disruptions at two crucial shipping chokepoints, namely the Suez Canal and the Panama Canal, resulted in increased costs for U.S. retailers, subsequently leading to higher prices for consumers. However, as the quarter progressed, prices declined due to cautious consumer attitudes towards the economy. Factors such as sluggish retail sales and subdued consumer spending contributed to this decline. Persistent inflationary pressures further compounded consumer caution, prompting a conservative approach to finances.
In conclusion, the pricing dynamics of Terbinafine Hydrochloride in the North America region during Q1 2024 were influenced by a combination of demand patterns, consumer sentiment, and inventory management strategies.
Asia Pacific
In the APAC region during Q1 2024, the pricing dynamics for Terbinafine Hydrochloride displayed a mixed pattern, influenced by several significant factors. Initially, prices saw an uptick as demand surged from both domestic and international markets, putting strain on the supply chain. Market participants responded by offering higher quotations to maximize profits. However, prices experienced a decline in February and March, primarily due to an oversupply situation in the domestic market. This oversupply was fueled by the robust expansion of India's manufacturing sector and a notable surge in factory output. Moreover, the continuation of elevated interest rates in key export destinations like the USA and Europe contributed to dampened foreign demand for the product. Additionally, the moderation in inflation rates and a decline in fuel prices played a role in reducing input costs for pharmaceutical manufacturers. Consequently, the lowered input costs translated into decreased production expenses for Terbinafine Hydrochloride, prompting manufacturers to adjust prices downward. This adjustment allowed them to pass on the resulting savings to consumers. As a result of these factors, the latest quarter-ending price for Terbinafine Hydrochloride (USP) Ex-Hyderabad in India stood at USD 53976 per metric ton.
Europe
In the first quarter of 2024, the pricing dynamics of Terbinafine Hydrochloride in Europe unfolded against a nuanced backdrop influenced by a myriad of factors. Initially, prices witnessed an uptick driven by geopolitical tensions, logistical hurdles, and constrained inventories. Additionally, heightened demand from the healthcare and pharmaceutical sectors exerted further influence on market dynamics. Concurrently, prolonged disruptions in the Red Sea complicated trade routes between Asia and Europe, resulting in escalated freight costs that impacted the pricing scenario of Terbinafine Hydrochloride, particularly in Germany. However, as the quarter progressed, prices experienced a decline in February and March, attributable to the market grappling with persistently lackluster performance in new industrial orders. This was characterized by insufficient domestic demand juxtaposed against a relatively high backlog, further contributing to the downward trajectory of Terbinafine Hydrochloride prices in the Europe region. Moreover, this decrease in demand, coupled with the central bank's decision to maintain existing interest rates, added complexity to the market environment by placing additional strain on consumers' purchasing power. In response to these challenges, market suppliers and traders endeavored to address excess inventories amidst sluggish domestic demand, working to navigate through the intricacies of the evolving market landscape.
For the Quarter Ending December 2023
North America
In the North American region, the pricing of Terbinafine Hydrochloride in the fourth quarter of 2023 (October to December) was shaped by several significant factors. Firstly, the market witnessed a modest decline in prices due to reduced demand from the pharmaceutical and healthcare sectors, leading to an oversupply. Additionally, the continual maintenance of high-interest rates by the Federal Reserve impacted consumer purchasing power, further contributing to the downward trend. Moreover, the decrease in Terbinafine Hydrochloride prices in key exporting countries such as China and India also influenced the USA market, as international prices saw a decline.
Focusing specifically on the USA market, Terbinafine Hydrochloride prices experienced a continuous decline throughout Q4, attributed to reduced demand from end-user industries and the impact of high-interest rates on consumer spending. In response to surplus supply and the potential for reduced demand, manufacturers and distributors adjusted by offering discounted quotations to clear excess inventory, especially towards the end of the year.
Overall, the Terbinafine Hydrochloride market reflected bearish sentiments in Q4, marked by sustained weak demand from consumers. However, a positive trajectory is anticipated with improved trade activities and steady demand from end-users.
APAC
Terbinafine Hydrochloride pricing in the APAC region during the fourth quarter of 2023 was influenced by several factors. Firstly, there was a decline in demand from the pharmaceutical and healthcare sectors, leading to a decrease in prices. Additionally, the market experienced an excess supply of Terbinafine Hydrochloride, further putting downward pressure on prices. Moreover, the global economic slowdown, particularly in advanced economies, resulted in a slowdown in global trade and weakened foreign demand, contributing to the overall bearish market sentiment. In terms of specific country insights, India experienced a slowdown in its manufacturing sector during the fourth quarter. This was reflected in a decrease in new orders, production levels, exports, and purchasing activity. The decline in demand and the excess supply of Terbinafine Hydrochloride in the domestic market led to lower prices. Furthermore, the arrival of the winter season resulted in a decrease in the prevalence of fungal infections, leading to reduced demand for Terbinafine Hydrochloride. Overall, the market dynamics remain positive, indicating a potential increase in prices in the coming months. The latest price of Terbinafine Hydrochloride (USP) Ex-Hyderabad in India for the fourth quarter of 2023 is USD 62471/MT.
Europe
In the fourth quarter of 2023, the Terbinafine Hydrochloride market in Europe underwent significant influences on prices. Market dynamics were shaped by factors including currency fluctuations, a tightening monetary policy, and weakened consumer sentiments. Firstly, there was a noticeable decrease in Terbinafine Hydrochloride demand due to subdued consumer spending and reduced consumption. This decline in demand was further intensified by the ongoing impact of high interest rates, constraining consumers' purchasing power. Additionally, the Euro appreciated against the US dollar, resulting in cost-effective imports and ensuring an ample supply of Terbinafine Hydrochloride in the German market. Moreover, heightened competition among suppliers led to a substantial reduction in prices. Despite these factors, Germany experienced a decline in inflation, providing some relief for consumers. The European Central Bank maintained its interest rate at 4%, further restricting the economy's growth potential and maintaining subdued overall demand. In summary, market experienced a decline in consumer confidence and a slowdown in its industrial sector, contributing to lower demand and prices.
For the Quarter Ending December 2022
North America
During the fourth quarter of 2022, Terbinafine Hydrochloride market dynamics were changing in the North American region. Prices were expected to increase through the second month of the quarter starting with Q4 2022 because of the high cost of manufacturing, numerous logistical issues, and rising inflation. Rising transportation costs and port congestion at the key ports also helped to keep the market position strong. Prices begin to decline later in December as a result of softening inflation and declining end-user sector demand. Values were accessed at USD 83520/MT CFR Houston at the end of Q4.
Asia
In the fourth quarter of 2022, the Terbinafine Hydrochloride market in the Asia Pacific region experienced erratic growth. At the beginning of Q4 2022, it was reported that rising end-user sector demand, a number of logistical issues, and rising inflation would cause prices to grow through the second month of the quarter. The strict zero covid regulations and frequent lockdowns in the Chinese provinces have had an effect on the market. Terbinafine Hydrochloride costs did, however, decrease later in December since domestic retailers had sufficient stock on hand. Additionally, the market remained weak due to the policies' easing and the lackluster downstream demand. Towards the end of Q4, the prices of Terbinafine Hydrochloride were recorded at USD 74400/ton FOB Shanghai.
Europe
Terbinafine Hydrochloride prices in the European region showed a see-saw tendency in the fourth quarter of 2022. Terbinafine Hydrochloride has been consistently in demand from the pharmaceutical industry's downstream market during the first two months of Q4 2022. The supply chain was impacted by the continuous port congestion and supply disruption in the European region, which led to price increases in the first two months of Q4 022. Terbinafine Hydrochloride trajectory was also affected by the high freight costs. Due to the impending holiday season and the need to meet it, European retailers have decided to refill their stocks in large quantities. Nevertheless, the prices drop in the month of December owing to existing inventories and lowering demand from the end-user sector. Towards the end of Q4 2022, the prices of Ivermectin were recorded at USD 853300/MT CFR Hamburg.
For the Quarter Ending September 2022
North America
Terbinafine Hydrochloride's market in North America saw a declining trend during the third quarter of 2022 because of steady demand from the downstream pharmaceutical industry. The global market for the raw material dichlorobenzene had consistent market sentiments. Since the Asian nations are the primary source of product supply for the North American region, a sufficient supply led to product availability in the local market. Due to ample stocks among domestic suppliers and slow demand from the downstream pharmaceutical industry, prices declined as Q3's second half finished. By the end of Q3 2022, Terbinafine Hydrochloride values were found at USD 82720/MT, with an average quarterly decline of 0.78%.
Asia
Global demand for Terbinafine Hydrochloride has been increasing since the beginning of the third quarter of 2022, owing to increasing market demand and improved market sentiments. Also, the market sentiments of raw material dichlorobenzene showcased rising market sentiments. At the onset of the second half of Q3, the prices dropped gradually due to a stabilization in demand from regional and overseas markets. Also, enough existing inventories among the domestic merchants to cater to consumer demand kept the market sentiments feeble. Towards the termination of Q3 2022, the prices were recorded to be USD 72800/MT with an average quarterly declination of 0.70%.
Europe
Terbinafine Hydrochloride prices were observed to be declining with a steady price trend until the third quarter of 2022. Furthermore, the Prices for feeds containing dichlorobenzene also demonstrated a declining trajectory with gradual stabilization. The Terbinafine Hydrochloride market remained weak due to existing stockpiles and a steady supply chain among domestic retailers. Lowering unit costs with stable operational activities also kept the market feeble. Terbinafine Hydrochloride prices were reported to be USD 84550/MT at the end of Q3 2022, with an average quarterly decline of 1.91%. The downstream pharmaceutical industry's continually declining demand caused the Terbinafine Hydrochloride market to be sluggish.
For the Quarter Ending June 2022
North America
In North America, the market of Terbinafine Hydrochloride showcased a decreasing trajectory throughout the quarter due to stable demand from the downstream pharmaceutical sector. The raw material dichlorobenzene market witnessed stable market sentiments globally. Since the North American region relies on the Asian countries for the supply of products, enough supply prompted the product availability in the regional market. With the commencement of the second half of Q2, the prices remained decelerating owing to enough inventories and sluggish demand from downstream pharmaceutical industry. Towards the end of Q2 2022, the values accessed for Terbinafine Hydrochloride at USD 89460/MT with the quarterly declination of 4.93%.
Asia
Global demand for Terbinafine Hydrochloride has been increasing since the beginning of this quarter owing to, increasing market demand and improved market sentiments. The dynamics of Terbinafine Hydrochloride were supported by gradually growing demand from downstream pharmaceutical industries. Also, the market sentiments of raw material dichlorobenzene also showcased rising market sentiments. At the onset of the second half of Q2, the prices increased due to increasing demand from regional and overseas markets. Also, with suspended transportation, port congestion, and route disruption, prices gradually increased with positive cost support. Towards the termination of Q2 2022, the prices were recorded to be USD 74420/MT with the quarterly inclination of 1.96%.
Europe
Prices of Terbinafine Hydrochloride were recorded to be accelerating with gradual stabilisation in price trajectory towards the termination of Q2 2022. The prices of feeds dichlorobenzene showcased a hiked-up market trajectory with gradual stabilisation. Suspended transportation and route disruption owing to geopolitical tension due to the Russia Ukraine war affected the prices to be on the slightly higher side of the price trajectory. Towards the outset of the second half of Q2 2022, Terbinafine Hydrochloride prices were recorded to be USD 84700/MT with the quarterly declination of 0.94%. With steadily increasing demand from the downstream pharmaceutical industry prompted the Terbinafine Hydrochloride market to be firm.
